Grantmaking public charity · EIN 26-3160079
Foundation for Angelman Syndrome Therapeutics
Austin, TX
Foundation for Angelman Syndrome Therapeutics is a public charity that makes grants based in Austin, TX. On its Form 990 (Schedule I) for tax year 2024, it reported $7.92M in grants paid across 10 grants, with $44.9M in total assets. Its largest grants went to University of Pennsylvania, Boston Children's Hospital and Rush University Medical Center.
How to request funding
Its Form 990 lists the grants it made but not how it chooses recipients. Check Foundation for Angelman Syndrome Therapeutics's website or contact it to ask whether it considers requests.
How it makes and monitors grants (Schedule I, Part IV)
The foundation requires semi-annual reports from the recipient of the funds which must include a progress status and an accounting of the funds. in addition, the foundation reserves the right to make periodic sight visits as deeemed necessary. the foundation may also obtain more infrequent informal updates via telephone or e-mail.
Grants as reported on its Form 990 for tax year 2024; the application guidance above is general for this type of funder. Requirements change; confirm with the organization before applying.
Mission
The foundation for angelman syndrome therapeutics (fast) is dedicated to finding a cure for angelman syndrome (as) and related disorders through the funding of an aggressive research agenda, education, awareness, and advocacy.
As stated on its Form 990.
Largest grants, tax year 2024
Historical data · not a prediction| Recipient | Location | Purpose | Amount |
|---|---|---|---|
| University of Pennsylvania | Philadelphia, PA | Upenn 2023: Research, Collaboration & License Agreement | $5,860,869 |
| Boston Children's Hospital | Boston, MA | Ft2022-006: Abom - Natural History Study | $470,957 |
| Rush University Medical Center | Chicago, IL | Rush Coe | $320,500 |
| Duke University | Charlotte, NC | Ft2018-005 Amended: Gpic-Comm | $317,848 |
| Regents of the University of California Davis | Davis, CA | Ft2022-007: Gastrointestinal Biomarkers in Preclinical Models of Angelman Syndrome | $274,044 |
| The Regents of the University of California San Francisco | San Francisco, CA | Ft2023-002: Developing a Crispra Therapy for the Classi/II Deletion Genotype of Angelman Syndrome | $210,711 |
| Brown University | Providence, RI | Ft2022-005: Development of Bdnf Potentiating Therapeutics for Motor and Cognitive Dysfunction in As | $150,000 |
| Children's Research Institute | Washington, DC | Ft2022-003: Peak Alpha Frequency As an Eeg Biomarker for Angelman Syndrome | $140,846 |
| Keck Graduate Institute of Applied Life Sciences | Claremont, CA | Ft2022-002: Targeting Angelman Syndrome Therapeutics to the Brain Utilizing Novel Cell Penetrating Peptides | $125,000 |
| Brown University | Providence, RI | Pd2023-001: Postdoctoral Fellowship Program | $50,500 |
Names and purposes as reported to the IRS.
Where its grants went
Quick answers
Does Foundation for Angelman Syndrome Therapeutics accept grant applications?
Its Form 990 lists the grants it made but not how it chooses recipients. Check Foundation for Angelman Syndrome Therapeutics's website or contact it to ask whether it considers requests. Form 990 does not report an application process, so confirm with the organization.
How much does Foundation for Angelman Syndrome Therapeutics give each year?
For tax year 2024, it reported $7,921,275 in grants paid (10 grants). Giving can change from year to year.
What organizations has Foundation for Angelman Syndrome Therapeutics funded?
Its largest grants in tax year 2024 went to University of Pennsylvania (PA), $5.86M, Boston Children's Hospital (MA), $471K, Rush University Medical Center (IL), $321K, Duke University (NC), $318K and Regents of the University of California Davis (CA), $274K.